Osmotica pharmaceuticals plc (OSMT)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-267,297

-270,901

-351,266

-241,816

-111,760

-109,681

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

44,584

57,015

70,855

76,697

79,151

81,573

0

0

0

Share compensation

4,870

4,932

0

0

0

-

-

-

-

Deferred income tax benefit

0

-

-

-

0

-

-

-

-

Deferred income tax benefit

-

-

-

-

-

-

0

0

0

Loss on sale of fixed and leased assets

-117

-173

0

0

0

-

-

-

-

Bad debt provision

-51

-164

-638

-1,688

-1,755

-1,771

0

0

0

Amortization of deferred financing and loan origination fees

1,347

1,337

1,391

1,469

1,560

1,652

0

0

0

Change in operating assets and liabilities:
Trade accounts receivable, net

-24,294

-12,674

-39,501

5,490

-5,832

17,041

0

0

0

Inventories, net

-7,279

-3,078

1,645

1,849

4,263

7,436

0

0

0

Prepaid expenses and other current assets

-5,377

-9,177

-16,274

-5,272

-6,139

-4,549

0

0

0

Other non‑current assets

0

-

-

-

-

-

-

-

0

Trade accounts payable

-11,807

-16,375

-17,227

-11,859

-47,787

-11,326

0

0

0

Accrued and other current liabilities

-27,907

-24,332

-16,225

320

1,840

5,397

0

0

0

Net cash used in operating activities

39,630

33,567

63,275

33,452

24,329

37,558

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of fixed and leased assets

0

-

-

-

-

-

-

-

-

Payments on disposal of leased assets

0

-

-

-

-

-

-

-

-

Purchase of property, plant and equipment

4,277

3,963

4,188

4,053

3,342

4,144

0

0

0

Net cash used in investing activities

-4,331

-4,020

-4,210

-4,043

-3,332

-4,134

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Payments to affiliates

-

-

-

-

-

2

0

0

0

Payments on finance lease obligations, ASC842

132

130

0

0

0

-

-

-

-

Payments on finance lease obligations, ASC840

-

-

-

-

-

112

0

0

0

Proceeds from public offering, net of issuance costs

0

-

-

-

-

-

-

-

-

Debt repayment

-

-

-

-

-

56,140

0

0

0

Repurchases of ordinary shares

0

-

-

-

-

-

-

-

-

Payments for taxes related to net share settlement of equity awards

0

-

-

-

-

-

-

-

-

Repayment of insurance financing loan

-

3,088

0

0

0

-

-

-

-

Net cash provided by (used in) financing activities

27,294

-4,691

6,525

6,127

4,669

3,604

0

0

0

Net change in cash and cash equivalents

62,593

24,856

65,590

35,535

25,666

37,028

0

0

0

Effect on cash of changes in exchange rate

-

-

-

-

-

-938

0

0

0

Supplemental disclosure of cash and non‑cash transactions:
Cash paid for interest

16,487

15,181

16,311

18,221

18,874

19,619

0

0

0

Cash paid for taxes

1,549

1,290

2,470

2,737

2,758

2,638

0

0

0